These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 20886327)

  • 21. Deranged calcium signaling in Purkinje cells and pathogenesis in spinocerebellar ataxia 2 (SCA2) and other ataxias.
    Kasumu A; Bezprozvanny I
    Cerebellum; 2012 Sep; 11(3):630-9. PubMed ID: 20480274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spinocerebellar ataxia type 6: Systematic patho-anatomical study reveals different phylogenetically defined regions of the cerebellum and neural pathways undergo different evolutions of the degenerative process.
    Wang X; Wang H; Xia Y; Jiang H; Shen L; Wang S; Shen R; Xu Q; Luo X; Tang B
    Neuropathology; 2010 Oct; 30(5):501-14. PubMed ID: 20113406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study.
    Guerrini L; Lolli F; Ginestroni A; Belli G; Della Nave R; Tessa C; Foresti S; Cosottini M; Piacentini S; Salvi F; Plasmati R; De Grandis D; Siciliano G; Filla A; Mascalchi M
    Brain; 2004 Aug; 127(Pt 8):1785-95. PubMed ID: 15240431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autosomal dominant cerebellar ataxias: Imaging biomarkers with high effect sizes.
    Adanyeguh IM; Perlbarg V; Henry PG; Rinaldi D; Petit E; Valabregue R; Brice A; Durr A; Mochel F
    Neuroimage Clin; 2018; 19():858-867. PubMed ID: 29922574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gray matter volume deficits in spinocerebellar ataxia: an optimized voxel based morphometric study.
    Goel G; Pal PK; Ravishankar S; Venkatasubramanian G; Jayakumar PN; Krishna N; Purushottam M; Saini J; Faruq M; Mukherji M; Jain S
    Parkinsonism Relat Disord; 2011 Aug; 17(7):521-7. PubMed ID: 21600833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spinocerebellar ataxia type 1 (SCA1): new pathoanatomical and clinico-pathological insights.
    Rüb U; Bürk K; Timmann D; den Dunnen W; Seidel K; Farrag K; Brunt E; Heinsen H; Egensperger R; Bornemann A; Schwarzacher S; Korf HW; Schöls L; Bohl J; Deller T
    Neuropathol Appl Neurobiol; 2012 Dec; 38(7):665-80. PubMed ID: 22309224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6.
    Reetz K; Costa AS; Mirzazade S; Lehmann A; Juzek A; Rakowicz M; Boguslawska R; Schöls L; Linnemann C; Mariotti C; Grisoli M; Dürr A; van de Warrenburg BP; Timmann D; Pandolfo M; Bauer P; Jacobi H; Hauser TK; Klockgether T; Schulz JB;
    Brain; 2013 Mar; 136(Pt 3):905-17. PubMed ID: 23423669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.
    Tang B; Liu C; Shen L; Dai H; Pan Q; Jing L; Ouyang S; Xia J
    Arch Neurol; 2000 Apr; 57(4):540-4. PubMed ID: 10768629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early activation of microglia and astrocytes in mouse models of spinocerebellar ataxia type 1.
    Cvetanovic M; Ingram M; Orr H; Opal P
    Neuroscience; 2015 Mar; 289():289-99. PubMed ID: 25595967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Choreiform movements in spinocerebellar ataxia type 1.
    Namekawa M; Takiyama Y; Ando Y; Sakoe K; Muramatsu SI; Fujimoto KI; Nishizawa M; Nakano I
    J Neurol Sci; 2001 Jun; 187(1-2):103-6. PubMed ID: 11440752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progress in pathogenesis studies of spinocerebellar ataxia type 1.
    Cummings CJ; Orr HT; Zoghbi HY
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1079-81. PubMed ID: 10434309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional connectivity changes related to cognitive and motor performance in spinocerebellar ataxia type 2.
    Hernandez-Castillo CR; Galvez V; Mercadillo RE; Díaz R; Yescas P; Martinez L; Ochoa A; Velazquez-Perez L; Fernandez-Ruiz J
    Mov Disord; 2015 Sep; 30(10):1391-9. PubMed ID: 26256273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological enhancement of mGlu1 metabotropic glutamate receptors causes a prolonged symptomatic benefit in a mouse model of spinocerebellar ataxia type 1.
    Notartomaso S; Zappulla C; Biagioni F; Cannella M; Bucci D; Mascio G; Scarselli P; Fazio F; Weisz F; Lionetto L; Simmaco M; Gradini R; Battaglia G; Signore M; Puliti A; Nicoletti F
    Mol Brain; 2013 Nov; 6():48. PubMed ID: 24252411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progression of microstructural damage in spinocerebellar ataxia type 2: a longitudinal DTI study.
    Mascalchi M; Toschi N; Giannelli M; Ginestroni A; Della Nave R; Nicolai E; Bianchi A; Tessa C; Salvatore E; Aiello M; Soricelli A; Diciotti S
    AJNR Am J Neuroradiol; 2015 Jun; 36(6):1096-101. PubMed ID: 25882284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Initial Symptom and Motor Progression in Spinocerebellar Ataxias.
    Luo L; Wang J; Lo RY; Figueroa KP; Pulst SM; Kuo PH; Perlman S; Wilmot G; Gomez CM; Schmahmann J; Paulson H; Shakkottai VG; Ying SH; Zesiewicz T; Bushara K; Geschwind M; Xia G; Subramony SH; Ashizawa T; Kuo SH
    Cerebellum; 2017 Jun; 16(3):615-622. PubMed ID: 27848087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterotopic Purkinje Cells: a Comparative Postmortem Study of Essential Tremor and Spinocerebellar Ataxias 1, 2, 3, and 6.
    Louis ED; Kuo SH; Tate WJ; Kelly GC; Gutierrez J; Cortes EP; Vonsattel JG; Faust PL
    Cerebellum; 2018 Apr; 17(2):104-110. PubMed ID: 28791574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A longitudinal investigation into cognition and disease progression in spinocerebellar ataxia types 1, 2, 3, 6, and 7.
    Moriarty A; Cook A; Hunt H; Adams ME; Cipolotti L; Giunti P
    Orphanet J Rare Dis; 2016 Jun; 11(1):82. PubMed ID: 27333979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intranuclear immunolocalization of 14-3-3 protein isoforms in brains with spinocerebellar ataxia type 1.
    Umahara T; Uchihara T; Yagishita S; Nakamura A; Tsuchiya K; Iwamoto T
    Neurosci Lett; 2007 Mar; 414(2):130-5. PubMed ID: 17224237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular genetics of hereditary spinocerebellar ataxia: mutation analysis of spinocerebellar ataxia genes and CAG/CTG repeat expansion detection in 225 Italian families.
    Brusco A; Gellera C; Cagnoli C; Saluto A; Castucci A; Michielotto C; Fetoni V; Mariotti C; Migone N; Di Donato S; Taroni F
    Arch Neurol; 2004 May; 61(5):727-33. PubMed ID: 15148151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The spinocerebellar ataxias.
    Paulson HL
    J Neuroophthalmol; 2009 Sep; 29(3):227-37. PubMed ID: 19726947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.